3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with dihydrorhodamine 123 in 1 studies
| Studies (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Trials (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Recent Studies (post-2010) (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Studies (dihydrorhodamine 123) | Trials (dihydrorhodamine 123) | Recent Studies (post-2010) (dihydrorhodamine 123) |
|---|---|---|---|---|---|
| 100 | 6 | 38 | 228 | 0 | 34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishima, Y; Iwao, Y; Maruyama, T; Matsushita, S; Nishi, K; Otagiri, M; Taguchi, K; Watanabe, H; Yamasaki, K | 1 |
1 other study(ies) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and dihydrorhodamine 123
| Article | Year |
|---|---|
Recombinant Human Serum Albumin Containing 3 Copies of Domain I, Has Significant in Vitro Antioxidative Capacity Compared to the Wild-Type.
Topics: Antioxidants; Furans; Hydrogen Peroxide; Ketoprofen; Ligands; Oxidation-Reduction; Propionates; Protein Binding; Protein Domains; Recombinant Proteins; Rhodamines; Serum Albumin, Human | 2017 |